Rosett Max bought IMNM
January 31, 2024 · Form 4 insider transaction
Rosett Max bought 175,000 shares of Immunome, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
175,000
Price
$0.00
Total value
N/A
InsiderRosett Max
RoleOfficer
CompanyImmunome, Inc. (IMNM)
SecurityStock option (right to buy)
Transaction codeA: Grant or award
Transaction dateJanuary 31, 2024
Filing dateJanuary 31, 2024
Shares owned after175,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
25% of the shares subject to the options vest on January 31, 2025, and one-thirty-sixth (1/36th) of the remaining shares subject to the options shall vest every month thereafter.